“Some times I awaken and will’t imagine how much we’ve come,” stated Dr. Doblin, 67, who now oversees the Multidisciplinary Affiliation for Psychedelic Research, a multimillion greenback exploration and advocacy empire that employs 130 neuroscientists, pharmacologists and regulatory experts Performing to lay the groundwork for the approachi